Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LibertyStream is a medical technology company that develops advanced respiratory therapy devices designed to improve lung function for patients with chronic pulmonary diseases. The company's flagship product is a portable oscillating positive expiratory pressure (OPEP) device that facilitates the clearance of excess mucus from the airways. By combining positive pressure with high-frequency oscillations, the device helps prevent mucus buildup, which is a common complication in conditions such as COPD, bronchiectasis, and cystic fibrosis. LibertyStream's solution is engineered to be easy to use, enhancing patient compliance and overall respiratory health outcomes. The company is headquartered in Houston, Texas, and its technology is FDA-cleared for commercial use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LibertyStream.